Treatment of postmenopausal osteoporosis in a patient with celiac disease

Nature Reviews Endocrinology

Volumn 6, Issue 3, 2010, Pages 167-171

  Pinkerton, Joann V ^a   Dalkin, Alan C ^a   Crowe, Sheila E ^a   Wilson, Barbara B ^a   Stelow, Edward B ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; GLUTEN; HORMONE; IBANDRONIC ACID; IMMUNOGLOBULIN A; IRON; OMEPRAZOLE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RALOXIFENE; VITAMIN D; ZOLEDRONIC ACID;

ADULT; ANEMIA; ANXIETY; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BREAST CANCER; CANCER RISK; CASE REPORT; CELIAC DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLONOSCOPY; DIET; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOSCOPIC BIOPSY; FATIGUE; FEMALE; FRAGILITY FRACTURE; GASTROESOPHAGEAL REFLUX; GLUTEN FREE DIET; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; IRON DEFICIENCY ANEMIA; LEG SWELLING; MEDICAL SPECIALIST; NIGHT SWEAT; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; SIDE EFFECT; VASOMOTOR DISORDER;

BONE DENSITY; CELIAC DISEASE; DIPHOSPHONATES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 77649083665     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.272     Document Type: Article

References (20)

1. Cauley, J. A. et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 290, 1729-1738 (2003).
2. Watts, N. B., Lewiecki, E. M., Miller, P. D. &Baim, S. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J. Clin. Densitom. 11, 473-477 (2008).
3. World Health Organization Collaborating Centre for Metabolic Bone Diseases WHO Fracture Risk Assessment Tool [online] http://www.shef.ac.uk/ FRAX/ (2009).
4. National Osteoporosis Foundation [online] http://www.nof.org/prevention/ risk.htm (2009).
5. Gail, M. H. et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl Cancer Inst. 81, 1879-1886 (1989).
6. Rostom, A. et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128 (Suppl. 1) S38-S46 (2005).
7. Rostom, A., Murray, J. A. &Kagnoff, M. F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131, 1981-2002 (2006).
8. AGA Institute. AGA Institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology 131, 1977-1980 (2006).
9. US Department of Health and Human Services. National Institutes of Health Consensus Development Conference Statement [online], http://consensus.nih.gov/ 2004/ 2004CeliacDisease118html.htm (2004).
10. Niewinski, M. M. Advances in celiac disease and gluten-free diet. J. Am. Diet Assoc. 108, 661-672 (2008).
11. Pietzak, M. M. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology 128 (Suppl. 1), S135-S141 (2005).
12. Chapuy, M. C. et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 7, 439-443 (1997).
13. Olmos, M. et al. Systematic review and metaanalysis of observational studies on the prevalence of fractures in coeliac disease. Dig. Liver Dis. 40, 46-53 (2008).
14. Legroux-Gérot, I. et al. Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 76, 162-165 (2009).
15. Kavuncu, V., Dundar, U., Ciftci, I. H., Evcik, D. &yigit, I. Is there any requirement for celiac disease screening routinely in postmenopausal women with osteoporosis? Rheumatol. Int. 29, 841-845 (2009).
16. yu, E. W. et al. Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif. Tissue Int. 83, 251-259 (2008).
17. Roux, C. et al. Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif. Tissue Int. 84, 13-19 (2009).
18. Mautalen, C. et al. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Am. J. Gastroenterol. 92, 313-318 (1997). (Pubitemid 27076483)
19. National Institute of Diabetes and Digestive and Kidney Diseases National Digestive Diseases Information Clearinghouse [online], http://digestive.niddk. nih.gov/ddiseases/ pubs/celiac/index.htm (2009).
20. Stenson, W. F., Newberry, R., Lorenz, R., Baldus, C. &Civitelli, R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch. Intern. Med. 165, 393-399 (2005).